Population-based cancer survival in China
Dr Hongmei Zeng PhD, Associate Professor, National Cancer Center of China
Cancer has become a leading cause of death in urban China and the second most common causes in rural China for many years. The burden of cancer in China is expected to increase as a result of population ageing, increased environmental pollution, uncontrolled chronic infection, and adoption of westernized lifestyles, including tobacco and harmful alcohol use, unhealthy diets and physical inactivity. Information on the overall effectiveness of cancer management is thus increasingly important. Due to its large population, the global burden of cancer is strongly influenced by the burden of cancer in China. However, Limited population-based cancer registry data available in China until now has hampered efforts to inform cancer control policy. In this Seminar, Dr. Hongmei Zeng will introduce the first systematic analysis exploring the overall profile of population-based cancer survival in the Chinese population, with a standardized protocol for data collection, quality control and analysis.
Dr. Hongmei Zeng is Associate Professor of Epidemiology in the National Office for Cancer Prevention and Control, Chinese Academy of Medical Sciences, Cancer Hospital/ National Cancer Center. Dr. Zeng received her PhD from Peking University in 2011. During 2009 and 2010, she was studying in Yale University School of Public Health. Dr. Zeng’s research interests are in the areas of cancer etiology and prevention, and in cancer registration.
Thursday, 14 April 2016
3:00pm – 4:00pm
Room 113, Public Health Building, Herston